BNP Digital Twin Biohybrid Neural Processor
Session 00:00
Mode Standby

Interactive Subdomain Experience

Simulate electrophysiology, compare compounds, and surface AI interpretation in one screen.

This enhanced dashboard turns the BNP concept into a product-style digital twin: live neural metrics, MEA activity mapping, pharmacodynamic patterns, and decision support signals built into a single branded interface.

64 ch

Simulated MEA Array

AI

Classification Engine

CNS

Drug Response Twin

Live Metrics

Neural state monitor

System ready
Mean firing rate8.4 HzBaseline
Network synchrony0.52 ρNormal
Burst frequency3.1 evt/minStable
Inter-spike interval119 msNormal

Simulation

Drug-response controls

Signals

Live electrophysiological traces

Spike trainChannel 1 · 8.4 Hz
MFR evolutionSteady baseline

MEA Hardware Panel

Acquisition integrity

Signal sourceSimulated MEA
Sampling rate25 kHz
Electrodes64 ch
Signal qualityExcellent
Impedance180 kΩ
Temperature37.0 °C
Electrode activity map (8×8) Live distribution

AI Classification Engine

Inference output

Drug classificationNo compound
Model confidence
Neurotoxicity riskLow
Predicted efficacy
Receptor pathwayBaseline
Clinical phase fitPhase 0
E/I balance indexBalanced
InhibitoryBalancedExcitatory
Model reasoning

Select a drug compound and run simulation to begin AI analysis.

Drug Comparison

Two-compound contrast

Diazepam

Difference profile

Ketamine

About BNP

Why this digital twin matters

The Biohybrid Neural Processor integrates living human neurons, microelectrode arrays, and AI models to simulate and analyse drug effects on functional neural networks in real time. This dashboard translates that concept into a credible product experience that can sit on a dedicated subdomain.

01

Living neuronal substrate

Human iPSC-derived neurons forming synaptically active networks in a controlled bioenvironment.

02

Signal acquisition & interface

High-density MEA captures firing patterns, burst dynamics, and network synchrony.

03

AI computational module

Models decode electrophysiology into pharmacodynamic profiles, efficacy signals, and toxicity cues.

>90%CNS drug candidates fail in trials
$2.6BAverage cost per CNS drug to market
115M+Animals used in research globally each year
~$500Target BNP assay cost vs $50K+ in vivo